Correlation Between Personnality Traits and Ability to Learn Oroesophageal Voice
NCT ID: NCT06856863
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-10-14
2028-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of our study is to ascertain whether salient personality traits (as measured by the TCI) are common to patients who succeed in learning VOO, compared with those who do not.
40 subjects who underwent total laryngectomy and had access to speech therapy will be included in this study. A speech assessment with audio recording will be performed and acoustic measurements will be taken. Subjects will also take the TCI-125. Finally, a perceptual evaluation by a jury of experts will categorize the subjects as good or poor speakers.
Inclusion period: 24 months Duration of subject participation: 1 day Total duration: 36 months
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Telepractice and Conventional Face-to-face Voice Therapy
NCT02922309
Comprehensive Voice Rehabilitation Program Compared With Vocal Function Exercises
NCT02409758
Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population
NCT05187910
Multimodal Analysis of Structural Voice Disorders Based on Speech and Stroboscopic Laryngoscope Video
NCT05348031
Analysis of Language and Auditory Abilities in Cochlear Implanted Children
NCT00947778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study of personality traits in patients able or unable to learn VOO
Test of personality : questionnary
The questionnary Temperament and Character Inventory (TCI) describes personality through temperament traits governed by the individual's neurobiological systems and predetermined by heredity; and character traits shaped by social and cognitive experience
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test of personality : questionnary
The questionnary Temperament and Character Inventory (TCI) describes personality through temperament traits governed by the individual's neurobiological systems and predetermined by heredity; and character traits shaped by social and cognitive experience
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* French-speaking patients
* MoCA score ≥ 16/30
* Patients who have undergone laryngectomy or total pharyngo-laryngectomy between 6 months and 5 years of age
* Patients who have agreed to learn VOO
* Patients who began speech therapy to learn VOO no more than five years ago
* Patients who have had access to speech therapy to learn VOO for at least six months (completed or ongoing)
* Patients who have received information about the study and have not expressed their opposition
* Patients who are beneficiaries of or entitled to social security coverage
Exclusion Criteria
* Patients who did not receive speech therapy to learn OVO postoperatively, or who received less than 6 months of therapy
* Patients with a related condition that prevents them from learning VOO (anatomical or physiological abnormality, esophageal stenosis)
* Patients with a related condition that may be responsible for speech or fluency disorders (developmental, organic, or functional speech and language disorders, stuttering, stammering, fluency disorders, neurological speech disorders)
* Patients with uncorrected hearing loss
* Patients unable to receive informed consent about the ongoing research due to impaired psychological or physical health
* MoCA score \<16/30
* Patients with definite depressive symptoms (HAD-D score ≥ 11)
* Patients in a period of exclusion from another research protocol at the time of collection of the non-opposition.
* Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women, etc.).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00022-47
Identifier Type: OTHER
Identifier Source: secondary_id
RCAPHM25_0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.